LifeStance Health Group CEO Bourdon David reported a code-J transaction involving 150,000 shares at $0 per share on 2026-09-02. Afterward, his reported ownership was 1,248,247 shares, giving investors an updated view of the CEO’s disclosed Equity position in LifeStance Health Group.
Key Highlights
- The transaction was recorded under SEC code J.
- The transaction date was 2 September 2026.
- Bourdon David’s reported ownership afterward was 1,248,247 shares.
LifeStance Health Group, Inc. (NASDAQ: LFST) CEO Bourdon David reported a transaction involving 150,000 shares. The reported price was $0 per share.
Transaction Details and Reported Ownership
The transaction was dated 2 September 2026. Bourdon David was identified as LifeStance Health Group’s chief executive officer. Following the transaction, his reported ownership stood at 1,248,247 shares.
FAQs
Q: What transaction did LifeStance CEO Bourdon David report?
A: Bourdon David reported a code-J transaction involving 150,000 LifeStance Health Group shares at $0 per share. The transaction was dated 2 September 2026.
Q: What was Bourdon David’s LifeStance share ownership afterward?
A: Bourdon David’s reported ownership after the transaction was 1,248,247 LifeStance Health Group shares. He is identified as the company’s chief executive officer.
Q: What does the LifeStance CEO transaction show investors?
A: The disclosure shows a transaction involving 150,000 shares at $0 per share and identifies the CEO’s subsequent reported ownership as 1,248,247 shares.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.